We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VICI icon
826
VICI Properties
VICI
$28.7B
$4K ﹤0.01%
173
– –
VLUE icon
827
iShares MSCI USA Value Factor ETF
VLUE
$9.59B
$4K ﹤0.01%
+52
New +$4.17K
VXUS icon
828
Vanguard Total International Stock ETF
VXUS
$164B
$4K ﹤0.01%
82
– –
PRSP
829
DELISTED
Perspecta Inc. Common Stock
PRSP
$4K ﹤0.01%
159
-220
-58% -$4.94K
AAL icon
830
American Airlines Group
AAL
$9.88B
$3K ﹤0.01%
106
-934
-90% -$30.2K
AAT
831
American Assets Trust
AAT
$1.39B
$3K ﹤0.01%
62
– –
AES icon
832
AES
AES
$10.5B
$3K ﹤0.01%
170
– –
ASML icon
833
ASML
ASML
$695B
$3K ﹤0.01%
13
– –
AVNS
834
DELISTED
Avanos Medical
AVNS
$3K ﹤0.01%
78
+28
+56% +$1.2K
BHF icon
835
Brighthouse Financial
BHF
$3.44B
$3K ﹤0.01%
88
-7
-7% -$270
BPT
836
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$3K ﹤0.01%
200
– –
CDNS icon
837
Cadence Design Systems
CDNS
$89B
$3K ﹤0.01%
45
– –
CGC
838
Canopy Growth
CGC
$431M
$3K ﹤0.01%
7
– –
CHRW icon
839
C.H. Robinson
CHRW
$17.1B
$3K ﹤0.01%
37
– –
CMA
840
DELISTED
Comerica
CMA
$3K ﹤0.01%
45
– –
COLM icon
841
Columbia Sportswear
COLM
$2.88B
$3K ﹤0.01%
30
– –
CPF icon
842
Central Pacific Financial
CPF
$997M
$3K ﹤0.01%
111
– –
CSGP icon
843
CoStar Group
CSGP
$12.4B
$3K ﹤0.01%
50
– –
DIA icon
844
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
$3K ﹤0.01%
10
– –
EWBC icon
845
East-West Bancorp
EWBC
$18.5B
$3K ﹤0.01%
+63
New +$3.02K
EXPE icon
846
Expedia Group
EXPE
$39.1B
$3K ﹤0.01%
25
– –
EXR icon
847
Extra Space Storage
EXR
$31B
$3K ﹤0.01%
32
– –
FMC icon
848
FMC
FMC
$1.28B
$3K ﹤0.01%
34
– –
GL icon
849
Globe Life
GL
$13.8B
$3K ﹤0.01%
32
– –
HALO icon
850
Halozyme
HALO
$11.6B
$3K ﹤0.01%
200
– –
32 33
34
35 36

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.